Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06209528 · ClinicalTrials.gov registry record
Assessing Neurophysiological and Cognitive Function in School Children
A clinical trial, sponsored by Life University.
- Completed
- Registry status
- 17
- Enrollment target
NCT06209528: Completed study, sponsored by Life University.
NCT06209528 is a clinical trial that has completed, run by Life University. The registered enrollment target is 17 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06209528 has completed, sponsored by Life University.
- COMPLETED
- Registry status
- 17 participants
- Enrollment target
Study Summary
This trial will investigate the feasibility of implementing our novel assessment battery in a neurodiverse pediatric population. More specifically, we want to assess our processes and procedures with respect to 1) recruitment rate (i.e., efficiency of our recruitment methods), 2) tolerability (i.e., proportion of participants able to wear the hardware without difficulty), 3) compliance (i.e., proportion of participants able to complete each task as instructed), 4) efficiency (i.e., time to completion of the test battery), and 5) data fidelity (i.e., proportion of test acquisitions with data suitable for subsequent analyses).
Primary Outcome
Total number of subjects enrolled
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2024-03-26 |
| Est. Completion | 2024-03-28 |
What the finished NCT06209528 record still lists
NCT06209528 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 17 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT06209528 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06209528 about?
NCT06209528 is a clinical study titled "Assessing Neurophysiological and Cognitive Function in School Children". This trial will investigate the feasibility of implementing our novel assessment battery in a neurodiverse pediatric population. More specifically, we want to assess our processes and procedures with respect to 1) recruitment rate (i.e., efficiency of our recruitment methods), 2) tolerability (i.e.,...
What is the current status of trial NCT06209528?
This trial is currently completed. The enrollment target is 17 participants. The study started on 2024-03-26. Estimated completion is 2024-03-28.
Who is sponsoring clinical trial NCT06209528?
This trial is sponsored by Life University, which has 13 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02090140 · 17 participants · NA
Microfracture Versus Adipose Derived Stem Cells for the Treatment of Articular Cartilage Defects
- NCT03317860 · 17 participants · NA
Improving Measurement and Treatment of Post-stroke Neglect
- NCT04356469 · 17 participants · Phase 2
TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Non-Malignant Hematological Disorders in Children
- NCT04414046 · 17 participants · Phase 2
TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Primary Immunodeficiency and Inherited Metabolic Disorders in Children
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI